OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, revenue was VND 684,708.91 million compared to VND 872,974.33 million a year ago. Net income was VND 97,767.86 million compared to VND 106,555.25 million a year ago. Basic earnings per share from continuing operations was VND 1,306 compared to VND 1,499 a year ago. Diluted earnings per share from continuing operations was VND 1,306 compared to VND 1,499 a year ago.